Daval, Mary http://orcid.org/0000-0002-9815-1602
Corré, Alain
Palpacuer, Clement
Housset, Juliette
Poillon, Guillaume
Eliezer, Michael
Verillaud, Benjamin
Slama, Dorsaf
Ayache, Denis
Herman, Philippe
Jourdaine, Clement
Hervé, Camille
El Bakkouri, Wissame
Salmon, Dominique
Hautefort, Charlotte
Funding for this research was provided by:
Direction Générale de l’offre de Soins
Article History
Received: 1 July 2020
Accepted: 4 July 2020
First Online: 20 July 2020
Ethics approval and consent to participate
: ANSM and CPP approved the study.MEDAECNAT-2020-04-00075 approval was granted on May 14, 2020 .CPP SUD EST II (2020-39) approval was granted on April 24, 2020. An amendment was accepted on June 3, 2020 to allow the inclusion of patients with persistent hyposmia up to 90 days after the onset of signs of COVID.We declare that we certify that this trial has received ethical approval from the appropriate ethical committee described above. Each participant has to read an information note and signed a consent form for participation.
: Not applicable
: The authors declare that they have no competing interests.